Global Bone Allografts Market
Global Bone Allografts Market

Bone Allografts Comprehensive Study by Type (Fresh or fresh-frozen bone., Freeze-dried bone allograft (FDBA), Demineralized freeze-dried bone allograft (DFDBA)), Application (Spine Fusion, Dental grafting, Bone Trauma, Other), Allografts forms (Osteochondral, Cortical, Cancellous, Others), Bone source (Autografts, Cadaver bones), End User (Hospitals, Orthopedic Clinics, Dental Clinics, Aesthetics Clinics, Ambulatory Care Centers, Others) Players and Region - Global Market Outlook to 2024

Bone Allografts Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Sep 2020 Edition 206 Pages 211 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study

A bone graft is a surgical procedure that is used to fix bones or joints that were damaged by trauma, and it is also used to replace bone that is missing to provide structural stability around the body, including the jawbone. Bone allografts is the tissue that is transplanted from one person to another. They typically come from a donor, or cadaver bone, it is safely ready to use, and available in large amounts. The benefits of allograft over the autografts is required one less procedure which must first be taken from the patient and the Surgical time is minimized and the recovery can be quicker. The allograft comes from a reputable and reliable tissue bank. According to the NCBI, Over 200,000 cases involving allografts are used per year in the US.5 The lack of donor site morbidity, general success of results, and decreased surgical times make allograft a popular alternative to the autologous bone graft.

The market study is being classified by Type (Fresh or fresh-frozen bone., Freeze-dried bone allograft (FDBA) and Demineralized freeze-dried bone allograft (DFDBA)), by Application (Spine Fusion, Dental grafting, Bone Trauma and Other) and major geographies with country level break-up.

Zimmer Biomet (United States), Arthrex(United States), B. Braun (Germany), DePuy Synthes Companies(United States), Wright Medical Group(Netherlands), Geistlich Pharma AG (Switzerland and Xtant Medical(United States) are some of the key players profiled in the study.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Bone Allografts market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Bone Allografts market by Type, Application and Region.

On the basis of geography, the market of Bone Allografts has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increasing Incidences Of Musculoskeletal Disorders
  • The growing clinical requirement for the bone grafting procedure
  • Growing prevalence of orthopedic disorders such as arthritis.
  • Rising demand for orthopedic procedures among the geriatric population

Market Trend
  • The emergence of Allografts Techniques

Restraints
  • High cost Associated With the Treatment

Opportunities
  • The Advancement in the technologies and the shift from autograft to allograft innovations of biocompatible synthetic bone grafts is boosting the growth opportunities of the market

Challenges
  • Risk of disease transmission from donor to recipient


Market Leaders and their expansionary development strategies
For instance in July 2020 medtronics Ireland based company has announced their acuqistion with medicrea. With this merger acquisitions Medtronic Will Become the First Company to Offer an Integrated Solution such as Artificial Intelligence-Driven Surgical Planning, Personalized Spinal Implants and Robotic Assisted Surgery.this will helps and strengthen Medtronic’s position as a global innovator in permiting technologies and solutions for spine surgery.

"As per FDA, Docket No. 2004D-0178 The Food and Drug Administration (FDA) is announcing the availability of the guidance entitled “Class II Special Controls Guidance Document: Dental Bone Grafting Material Devices.” This guidance document describes a means by which class II dental bone grafting material devices may comply with the requirement of special controls."

Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Bone Allografts Manufacturer, Raw Material Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Fresh or fresh-frozen bone.
  • Freeze-dried bone allograft (FDBA)
  • Demineralized freeze-dried bone allograft (DFDBA)
By Application
  • Spine Fusion
  • Dental grafting
  • Bone Trauma
  • Other
By Allografts forms
  • Osteochondral
  • Cortical
  • Cancellous
  • Others

By Bone source
  • Autografts
  • Cadaver bones

By End User
  • Hospitals
  • Orthopedic Clinics
  • Dental Clinics
  • Aesthetics Clinics
  • Ambulatory Care Centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Incidences Of Musculoskeletal Disorders
      • 3.2.2. The growing clinical requirement for the bone grafting procedure
      • 3.2.3. Growing prevalence of orthopedic disorders such as arthritis.
      • 3.2.4. Rising demand for orthopedic procedures among the geriatric population
    • 3.3. Market Challenges
      • 3.3.1. Risk of disease transmission from donor to recipient
    • 3.4. Market Trends
      • 3.4.1. The emergence of Allografts Techniques
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Bone Allografts, by Type, Application, Allografts forms, Bone source, End User and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Bone Allografts (Value)
      • 5.2.1. Global Bone Allografts by: Type (Value)
        • 5.2.1.1. Fresh or fresh-frozen bone.
        • 5.2.1.2. Freeze-dried bone allograft (FDBA)
        • 5.2.1.3. Demineralized freeze-dried bone allograft (DFDBA)
      • 5.2.2. Global Bone Allografts by: Application (Value)
        • 5.2.2.1. Spine Fusion
        • 5.2.2.2. Dental grafting
        • 5.2.2.3. Bone Trauma
        • 5.2.2.4. Other
      • 5.2.3. Global Bone Allografts by: Allografts forms (Value)
        • 5.2.3.1. Osteochondral
        • 5.2.3.2. Cortical
        • 5.2.3.3. Cancellous
        • 5.2.3.4. Others
      • 5.2.4. Global Bone Allografts by: Bone source (Value)
        • 5.2.4.1. Autografts
        • 5.2.4.2. Cadaver bones
      • 5.2.5. Global Bone Allografts by: End User (Value)
        • 5.2.5.1. Hospitals
        • 5.2.5.2. Orthopedic Clinics
        • 5.2.5.3. Dental Clinics
        • 5.2.5.4. Aesthetics Clinics
        • 5.2.5.5. Ambulatory Care Centers
        • 5.2.5.6. Others
      • 5.2.6. Global Bone Allografts Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Bone Allografts: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Zimmer Biomet (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Arthrex(United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. B. Braun (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. DePuy Synthes Companies(United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Wright Medical Group(Netherlands)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Geistlich Pharma AG (Switzerland
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Xtant Medical(United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
  • 7. Global Bone Allografts Sale, by Type, Application, Allografts forms, Bone source, End User and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Bone Allografts (Value)
      • 7.2.1. Global Bone Allografts by: Type (Value)
        • 7.2.1.1. Fresh or fresh-frozen bone.
        • 7.2.1.2. Freeze-dried bone allograft (FDBA)
        • 7.2.1.3. Demineralized freeze-dried bone allograft (DFDBA)
      • 7.2.2. Global Bone Allografts by: Application (Value)
        • 7.2.2.1. Spine Fusion
        • 7.2.2.2. Dental grafting
        • 7.2.2.3. Bone Trauma
        • 7.2.2.4. Other
      • 7.2.3. Global Bone Allografts by: Allografts forms (Value)
        • 7.2.3.1. Osteochondral
        • 7.2.3.2. Cortical
        • 7.2.3.3. Cancellous
        • 7.2.3.4. Others
      • 7.2.4. Global Bone Allografts by: Bone source (Value)
        • 7.2.4.1. Autografts
        • 7.2.4.2. Cadaver bones
      • 7.2.5. Global Bone Allografts by: End User (Value)
        • 7.2.5.1. Hospitals
        • 7.2.5.2. Orthopedic Clinics
        • 7.2.5.3. Dental Clinics
        • 7.2.5.4. Aesthetics Clinics
        • 7.2.5.5. Ambulatory Care Centers
        • 7.2.5.6. Others
      • 7.2.6. Global Bone Allografts Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Bone Allografts: by Type(USD Million)
  • Table 2. Bone Allografts Fresh or fresh-frozen bone. , by Region USD Million (2013-2018)
  • Table 3. Bone Allografts Freeze-dried bone allograft (FDBA) , by Region USD Million (2013-2018)
  • Table 4. Bone Allografts Demineralized freeze-dried bone allograft (DFDBA) , by Region USD Million (2013-2018)
  • Table 5. Bone Allografts: by Application(USD Million)
  • Table 6. Bone Allografts Spine Fusion , by Region USD Million (2013-2018)
  • Table 7. Bone Allografts Dental grafting , by Region USD Million (2013-2018)
  • Table 8. Bone Allografts Bone Trauma , by Region USD Million (2013-2018)
  • Table 9. Bone Allografts Other , by Region USD Million (2013-2018)
  • Table 10. Bone Allografts: by Allografts forms(USD Million)
  • Table 11. Bone Allografts Osteochondral , by Region USD Million (2013-2018)
  • Table 12. Bone Allografts Cortical , by Region USD Million (2013-2018)
  • Table 13. Bone Allografts Cancellous , by Region USD Million (2013-2018)
  • Table 14. Bone Allografts Others , by Region USD Million (2013-2018)
  • Table 15. Bone Allografts: by Bone source(USD Million)
  • Table 16. Bone Allografts Autografts , by Region USD Million (2013-2018)
  • Table 17. Bone Allografts Cadaver bones , by Region USD Million (2013-2018)
  • Table 18. Bone Allografts: by End User(USD Million)
  • Table 19. Bone Allografts Hospitals , by Region USD Million (2013-2018)
  • Table 20. Bone Allografts Orthopedic Clinics , by Region USD Million (2013-2018)
  • Table 21. Bone Allografts Dental Clinics , by Region USD Million (2013-2018)
  • Table 22. Bone Allografts Aesthetics Clinics , by Region USD Million (2013-2018)
  • Table 23. Bone Allografts Ambulatory Care Centers , by Region USD Million (2013-2018)
  • Table 24. Bone Allografts Others , by Region USD Million (2013-2018)
  • Table 25. South America Bone Allografts, by Country USD Million (2013-2018)
  • Table 26. South America Bone Allografts, by Type USD Million (2013-2018)
  • Table 27. South America Bone Allografts, by Application USD Million (2013-2018)
  • Table 28. South America Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 29. South America Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 30. South America Bone Allografts, by End User USD Million (2013-2018)
  • Table 31. Brazil Bone Allografts, by Type USD Million (2013-2018)
  • Table 32. Brazil Bone Allografts, by Application USD Million (2013-2018)
  • Table 33. Brazil Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 34. Brazil Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 35. Brazil Bone Allografts, by End User USD Million (2013-2018)
  • Table 36. Argentina Bone Allografts, by Type USD Million (2013-2018)
  • Table 37. Argentina Bone Allografts, by Application USD Million (2013-2018)
  • Table 38. Argentina Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 39. Argentina Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 40. Argentina Bone Allografts, by End User USD Million (2013-2018)
  • Table 41. Rest of South America Bone Allografts, by Type USD Million (2013-2018)
  • Table 42. Rest of South America Bone Allografts, by Application USD Million (2013-2018)
  • Table 43. Rest of South America Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 44. Rest of South America Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 45. Rest of South America Bone Allografts, by End User USD Million (2013-2018)
  • Table 46. Asia Pacific Bone Allografts, by Country USD Million (2013-2018)
  • Table 47. Asia Pacific Bone Allografts, by Type USD Million (2013-2018)
  • Table 48. Asia Pacific Bone Allografts, by Application USD Million (2013-2018)
  • Table 49. Asia Pacific Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 50. Asia Pacific Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 51. Asia Pacific Bone Allografts, by End User USD Million (2013-2018)
  • Table 52. China Bone Allografts, by Type USD Million (2013-2018)
  • Table 53. China Bone Allografts, by Application USD Million (2013-2018)
  • Table 54. China Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 55. China Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 56. China Bone Allografts, by End User USD Million (2013-2018)
  • Table 57. Japan Bone Allografts, by Type USD Million (2013-2018)
  • Table 58. Japan Bone Allografts, by Application USD Million (2013-2018)
  • Table 59. Japan Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 60. Japan Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 61. Japan Bone Allografts, by End User USD Million (2013-2018)
  • Table 62. India Bone Allografts, by Type USD Million (2013-2018)
  • Table 63. India Bone Allografts, by Application USD Million (2013-2018)
  • Table 64. India Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 65. India Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 66. India Bone Allografts, by End User USD Million (2013-2018)
  • Table 67. South Korea Bone Allografts, by Type USD Million (2013-2018)
  • Table 68. South Korea Bone Allografts, by Application USD Million (2013-2018)
  • Table 69. South Korea Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 70. South Korea Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 71. South Korea Bone Allografts, by End User USD Million (2013-2018)
  • Table 72. Taiwan Bone Allografts, by Type USD Million (2013-2018)
  • Table 73. Taiwan Bone Allografts, by Application USD Million (2013-2018)
  • Table 74. Taiwan Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 75. Taiwan Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 76. Taiwan Bone Allografts, by End User USD Million (2013-2018)
  • Table 77. Australia Bone Allografts, by Type USD Million (2013-2018)
  • Table 78. Australia Bone Allografts, by Application USD Million (2013-2018)
  • Table 79. Australia Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 80. Australia Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 81. Australia Bone Allografts, by End User USD Million (2013-2018)
  • Table 82. Rest of Asia-Pacific Bone Allografts, by Type USD Million (2013-2018)
  • Table 83. Rest of Asia-Pacific Bone Allografts, by Application USD Million (2013-2018)
  • Table 84. Rest of Asia-Pacific Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 85. Rest of Asia-Pacific Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 86. Rest of Asia-Pacific Bone Allografts, by End User USD Million (2013-2018)
  • Table 87. Europe Bone Allografts, by Country USD Million (2013-2018)
  • Table 88. Europe Bone Allografts, by Type USD Million (2013-2018)
  • Table 89. Europe Bone Allografts, by Application USD Million (2013-2018)
  • Table 90. Europe Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 91. Europe Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 92. Europe Bone Allografts, by End User USD Million (2013-2018)
  • Table 93. Germany Bone Allografts, by Type USD Million (2013-2018)
  • Table 94. Germany Bone Allografts, by Application USD Million (2013-2018)
  • Table 95. Germany Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 96. Germany Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 97. Germany Bone Allografts, by End User USD Million (2013-2018)
  • Table 98. France Bone Allografts, by Type USD Million (2013-2018)
  • Table 99. France Bone Allografts, by Application USD Million (2013-2018)
  • Table 100. France Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 101. France Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 102. France Bone Allografts, by End User USD Million (2013-2018)
  • Table 103. Italy Bone Allografts, by Type USD Million (2013-2018)
  • Table 104. Italy Bone Allografts, by Application USD Million (2013-2018)
  • Table 105. Italy Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 106. Italy Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 107. Italy Bone Allografts, by End User USD Million (2013-2018)
  • Table 108. United Kingdom Bone Allografts, by Type USD Million (2013-2018)
  • Table 109. United Kingdom Bone Allografts, by Application USD Million (2013-2018)
  • Table 110. United Kingdom Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 111. United Kingdom Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 112. United Kingdom Bone Allografts, by End User USD Million (2013-2018)
  • Table 113. Netherlands Bone Allografts, by Type USD Million (2013-2018)
  • Table 114. Netherlands Bone Allografts, by Application USD Million (2013-2018)
  • Table 115. Netherlands Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 116. Netherlands Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 117. Netherlands Bone Allografts, by End User USD Million (2013-2018)
  • Table 118. Rest of Europe Bone Allografts, by Type USD Million (2013-2018)
  • Table 119. Rest of Europe Bone Allografts, by Application USD Million (2013-2018)
  • Table 120. Rest of Europe Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 121. Rest of Europe Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 122. Rest of Europe Bone Allografts, by End User USD Million (2013-2018)
  • Table 123. MEA Bone Allografts, by Country USD Million (2013-2018)
  • Table 124. MEA Bone Allografts, by Type USD Million (2013-2018)
  • Table 125. MEA Bone Allografts, by Application USD Million (2013-2018)
  • Table 126. MEA Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 127. MEA Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 128. MEA Bone Allografts, by End User USD Million (2013-2018)
  • Table 129. Middle East Bone Allografts, by Type USD Million (2013-2018)
  • Table 130. Middle East Bone Allografts, by Application USD Million (2013-2018)
  • Table 131. Middle East Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 132. Middle East Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 133. Middle East Bone Allografts, by End User USD Million (2013-2018)
  • Table 134. Africa Bone Allografts, by Type USD Million (2013-2018)
  • Table 135. Africa Bone Allografts, by Application USD Million (2013-2018)
  • Table 136. Africa Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 137. Africa Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 138. Africa Bone Allografts, by End User USD Million (2013-2018)
  • Table 139. North America Bone Allografts, by Country USD Million (2013-2018)
  • Table 140. North America Bone Allografts, by Type USD Million (2013-2018)
  • Table 141. North America Bone Allografts, by Application USD Million (2013-2018)
  • Table 142. North America Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 143. North America Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 144. North America Bone Allografts, by End User USD Million (2013-2018)
  • Table 145. United States Bone Allografts, by Type USD Million (2013-2018)
  • Table 146. United States Bone Allografts, by Application USD Million (2013-2018)
  • Table 147. United States Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 148. United States Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 149. United States Bone Allografts, by End User USD Million (2013-2018)
  • Table 150. Canada Bone Allografts, by Type USD Million (2013-2018)
  • Table 151. Canada Bone Allografts, by Application USD Million (2013-2018)
  • Table 152. Canada Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 153. Canada Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 154. Canada Bone Allografts, by End User USD Million (2013-2018)
  • Table 155. Mexico Bone Allografts, by Type USD Million (2013-2018)
  • Table 156. Mexico Bone Allografts, by Application USD Million (2013-2018)
  • Table 157. Mexico Bone Allografts, by Allografts forms USD Million (2013-2018)
  • Table 158. Mexico Bone Allografts, by Bone source USD Million (2013-2018)
  • Table 159. Mexico Bone Allografts, by End User USD Million (2013-2018)
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Bone Allografts: by Type(USD Million)
  • Table 168. Bone Allografts Fresh or fresh-frozen bone. , by Region USD Million (2019-2024)
  • Table 169. Bone Allografts Freeze-dried bone allograft (FDBA) , by Region USD Million (2019-2024)
  • Table 170. Bone Allografts Demineralized freeze-dried bone allograft (DFDBA) , by Region USD Million (2019-2024)
  • Table 171. Bone Allografts: by Application(USD Million)
  • Table 172. Bone Allografts Spine Fusion , by Region USD Million (2019-2024)
  • Table 173. Bone Allografts Dental grafting , by Region USD Million (2019-2024)
  • Table 174. Bone Allografts Bone Trauma , by Region USD Million (2019-2024)
  • Table 175. Bone Allografts Other , by Region USD Million (2019-2024)
  • Table 176. Bone Allografts: by Allografts forms(USD Million)
  • Table 177. Bone Allografts Osteochondral , by Region USD Million (2019-2024)
  • Table 178. Bone Allografts Cortical , by Region USD Million (2019-2024)
  • Table 179. Bone Allografts Cancellous , by Region USD Million (2019-2024)
  • Table 180. Bone Allografts Others , by Region USD Million (2019-2024)
  • Table 181. Bone Allografts: by Bone source(USD Million)
  • Table 182. Bone Allografts Autografts , by Region USD Million (2019-2024)
  • Table 183. Bone Allografts Cadaver bones , by Region USD Million (2019-2024)
  • Table 184. Bone Allografts: by End User(USD Million)
  • Table 185. Bone Allografts Hospitals , by Region USD Million (2019-2024)
  • Table 186. Bone Allografts Orthopedic Clinics , by Region USD Million (2019-2024)
  • Table 187. Bone Allografts Dental Clinics , by Region USD Million (2019-2024)
  • Table 188. Bone Allografts Aesthetics Clinics , by Region USD Million (2019-2024)
  • Table 189. Bone Allografts Ambulatory Care Centers , by Region USD Million (2019-2024)
  • Table 190. Bone Allografts Others , by Region USD Million (2019-2024)
  • Table 191. South America Bone Allografts, by Country USD Million (2019-2024)
  • Table 192. South America Bone Allografts, by Type USD Million (2019-2024)
  • Table 193. South America Bone Allografts, by Application USD Million (2019-2024)
  • Table 194. South America Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 195. South America Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 196. South America Bone Allografts, by End User USD Million (2019-2024)
  • Table 197. Brazil Bone Allografts, by Type USD Million (2019-2024)
  • Table 198. Brazil Bone Allografts, by Application USD Million (2019-2024)
  • Table 199. Brazil Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 200. Brazil Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 201. Brazil Bone Allografts, by End User USD Million (2019-2024)
  • Table 202. Argentina Bone Allografts, by Type USD Million (2019-2024)
  • Table 203. Argentina Bone Allografts, by Application USD Million (2019-2024)
  • Table 204. Argentina Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 205. Argentina Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 206. Argentina Bone Allografts, by End User USD Million (2019-2024)
  • Table 207. Rest of South America Bone Allografts, by Type USD Million (2019-2024)
  • Table 208. Rest of South America Bone Allografts, by Application USD Million (2019-2024)
  • Table 209. Rest of South America Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 210. Rest of South America Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 211. Rest of South America Bone Allografts, by End User USD Million (2019-2024)
  • Table 212. Asia Pacific Bone Allografts, by Country USD Million (2019-2024)
  • Table 213. Asia Pacific Bone Allografts, by Type USD Million (2019-2024)
  • Table 214. Asia Pacific Bone Allografts, by Application USD Million (2019-2024)
  • Table 215. Asia Pacific Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 216. Asia Pacific Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 217. Asia Pacific Bone Allografts, by End User USD Million (2019-2024)
  • Table 218. China Bone Allografts, by Type USD Million (2019-2024)
  • Table 219. China Bone Allografts, by Application USD Million (2019-2024)
  • Table 220. China Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 221. China Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 222. China Bone Allografts, by End User USD Million (2019-2024)
  • Table 223. Japan Bone Allografts, by Type USD Million (2019-2024)
  • Table 224. Japan Bone Allografts, by Application USD Million (2019-2024)
  • Table 225. Japan Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 226. Japan Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 227. Japan Bone Allografts, by End User USD Million (2019-2024)
  • Table 228. India Bone Allografts, by Type USD Million (2019-2024)
  • Table 229. India Bone Allografts, by Application USD Million (2019-2024)
  • Table 230. India Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 231. India Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 232. India Bone Allografts, by End User USD Million (2019-2024)
  • Table 233. South Korea Bone Allografts, by Type USD Million (2019-2024)
  • Table 234. South Korea Bone Allografts, by Application USD Million (2019-2024)
  • Table 235. South Korea Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 236. South Korea Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 237. South Korea Bone Allografts, by End User USD Million (2019-2024)
  • Table 238. Taiwan Bone Allografts, by Type USD Million (2019-2024)
  • Table 239. Taiwan Bone Allografts, by Application USD Million (2019-2024)
  • Table 240. Taiwan Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 241. Taiwan Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 242. Taiwan Bone Allografts, by End User USD Million (2019-2024)
  • Table 243. Australia Bone Allografts, by Type USD Million (2019-2024)
  • Table 244. Australia Bone Allografts, by Application USD Million (2019-2024)
  • Table 245. Australia Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 246. Australia Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 247. Australia Bone Allografts, by End User USD Million (2019-2024)
  • Table 248. Rest of Asia-Pacific Bone Allografts, by Type USD Million (2019-2024)
  • Table 249. Rest of Asia-Pacific Bone Allografts, by Application USD Million (2019-2024)
  • Table 250. Rest of Asia-Pacific Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 251. Rest of Asia-Pacific Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 252. Rest of Asia-Pacific Bone Allografts, by End User USD Million (2019-2024)
  • Table 253. Europe Bone Allografts, by Country USD Million (2019-2024)
  • Table 254. Europe Bone Allografts, by Type USD Million (2019-2024)
  • Table 255. Europe Bone Allografts, by Application USD Million (2019-2024)
  • Table 256. Europe Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 257. Europe Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 258. Europe Bone Allografts, by End User USD Million (2019-2024)
  • Table 259. Germany Bone Allografts, by Type USD Million (2019-2024)
  • Table 260. Germany Bone Allografts, by Application USD Million (2019-2024)
  • Table 261. Germany Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 262. Germany Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 263. Germany Bone Allografts, by End User USD Million (2019-2024)
  • Table 264. France Bone Allografts, by Type USD Million (2019-2024)
  • Table 265. France Bone Allografts, by Application USD Million (2019-2024)
  • Table 266. France Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 267. France Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 268. France Bone Allografts, by End User USD Million (2019-2024)
  • Table 269. Italy Bone Allografts, by Type USD Million (2019-2024)
  • Table 270. Italy Bone Allografts, by Application USD Million (2019-2024)
  • Table 271. Italy Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 272. Italy Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 273. Italy Bone Allografts, by End User USD Million (2019-2024)
  • Table 274. United Kingdom Bone Allografts, by Type USD Million (2019-2024)
  • Table 275. United Kingdom Bone Allografts, by Application USD Million (2019-2024)
  • Table 276. United Kingdom Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 277. United Kingdom Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 278. United Kingdom Bone Allografts, by End User USD Million (2019-2024)
  • Table 279. Netherlands Bone Allografts, by Type USD Million (2019-2024)
  • Table 280. Netherlands Bone Allografts, by Application USD Million (2019-2024)
  • Table 281. Netherlands Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 282. Netherlands Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 283. Netherlands Bone Allografts, by End User USD Million (2019-2024)
  • Table 284. Rest of Europe Bone Allografts, by Type USD Million (2019-2024)
  • Table 285. Rest of Europe Bone Allografts, by Application USD Million (2019-2024)
  • Table 286. Rest of Europe Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 287. Rest of Europe Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 288. Rest of Europe Bone Allografts, by End User USD Million (2019-2024)
  • Table 289. MEA Bone Allografts, by Country USD Million (2019-2024)
  • Table 290. MEA Bone Allografts, by Type USD Million (2019-2024)
  • Table 291. MEA Bone Allografts, by Application USD Million (2019-2024)
  • Table 292. MEA Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 293. MEA Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 294. MEA Bone Allografts, by End User USD Million (2019-2024)
  • Table 295. Middle East Bone Allografts, by Type USD Million (2019-2024)
  • Table 296. Middle East Bone Allografts, by Application USD Million (2019-2024)
  • Table 297. Middle East Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 298. Middle East Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 299. Middle East Bone Allografts, by End User USD Million (2019-2024)
  • Table 300. Africa Bone Allografts, by Type USD Million (2019-2024)
  • Table 301. Africa Bone Allografts, by Application USD Million (2019-2024)
  • Table 302. Africa Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 303. Africa Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 304. Africa Bone Allografts, by End User USD Million (2019-2024)
  • Table 305. North America Bone Allografts, by Country USD Million (2019-2024)
  • Table 306. North America Bone Allografts, by Type USD Million (2019-2024)
  • Table 307. North America Bone Allografts, by Application USD Million (2019-2024)
  • Table 308. North America Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 309. North America Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 310. North America Bone Allografts, by End User USD Million (2019-2024)
  • Table 311. United States Bone Allografts, by Type USD Million (2019-2024)
  • Table 312. United States Bone Allografts, by Application USD Million (2019-2024)
  • Table 313. United States Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 314. United States Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 315. United States Bone Allografts, by End User USD Million (2019-2024)
  • Table 316. Canada Bone Allografts, by Type USD Million (2019-2024)
  • Table 317. Canada Bone Allografts, by Application USD Million (2019-2024)
  • Table 318. Canada Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 319. Canada Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 320. Canada Bone Allografts, by End User USD Million (2019-2024)
  • Table 321. Mexico Bone Allografts, by Type USD Million (2019-2024)
  • Table 322. Mexico Bone Allografts, by Application USD Million (2019-2024)
  • Table 323. Mexico Bone Allografts, by Allografts forms USD Million (2019-2024)
  • Table 324. Mexico Bone Allografts, by Bone source USD Million (2019-2024)
  • Table 325. Mexico Bone Allografts, by End User USD Million (2019-2024)
  • Table 326. Research Programs/Design for This Report
  • Table 327. Key Data Information from Secondary Sources
  • Table 328. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Bone Allografts: by Type USD Million (2013-2018)
  • Figure 5. Global Bone Allografts: by Application USD Million (2013-2018)
  • Figure 6. Global Bone Allografts: by Allografts forms USD Million (2013-2018)
  • Figure 7. Global Bone Allografts: by Bone source USD Million (2013-2018)
  • Figure 8. Global Bone Allografts: by End User USD Million (2013-2018)
  • Figure 9. South America Bone Allografts Share (%), by Country
  • Figure 10. Asia Pacific Bone Allografts Share (%), by Country
  • Figure 11. Europe Bone Allografts Share (%), by Country
  • Figure 12. MEA Bone Allografts Share (%), by Country
  • Figure 13. North America Bone Allografts Share (%), by Country
  • Figure 14. Global Bone Allografts share by Players 2018 (%)
  • Figure 15. Global Bone Allografts share by Players (Top 3) 2018(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Zimmer Biomet (United States) Revenue, Net Income and Gross profit
  • Figure 18. Zimmer Biomet (United States) Revenue: by Geography 2018
  • Figure 19. Arthrex(United States) Revenue, Net Income and Gross profit
  • Figure 20. Arthrex(United States) Revenue: by Geography 2018
  • Figure 21. B. Braun (Germany) Revenue, Net Income and Gross profit
  • Figure 22. B. Braun (Germany) Revenue: by Geography 2018
  • Figure 23. DePuy Synthes Companies(United States) Revenue, Net Income and Gross profit
  • Figure 24. DePuy Synthes Companies(United States) Revenue: by Geography 2018
  • Figure 25. Wright Medical Group(Netherlands) Revenue, Net Income and Gross profit
  • Figure 26. Wright Medical Group(Netherlands) Revenue: by Geography 2018
  • Figure 27. Geistlich Pharma AG (Switzerland Revenue, Net Income and Gross profit
  • Figure 28. Geistlich Pharma AG (Switzerland Revenue: by Geography 2018
  • Figure 29. Xtant Medical(United States) Revenue, Net Income and Gross profit
  • Figure 30. Xtant Medical(United States) Revenue: by Geography 2018
  • Figure 31. Global Bone Allografts: by Type USD Million (2019-2024)
  • Figure 32. Global Bone Allografts: by Application USD Million (2019-2024)
  • Figure 33. Global Bone Allografts: by Allografts forms USD Million (2019-2024)
  • Figure 34. Global Bone Allografts: by Bone source USD Million (2019-2024)
  • Figure 35. Global Bone Allografts: by End User USD Million (2019-2024)
  • Figure 36. South America Bone Allografts Share (%), by Country
  • Figure 37. Asia Pacific Bone Allografts Share (%), by Country
  • Figure 38. Europe Bone Allografts Share (%), by Country
  • Figure 39. MEA Bone Allografts Share (%), by Country
  • Figure 40. North America Bone Allografts Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Zimmer Biomet (United States)
  • Arthrex(United States)
  • B. Braun (Germany)
  • DePuy Synthes Companies(United States)
  • Wright Medical Group(Netherlands)
  • Geistlich Pharma AG (Switzerland
  • Xtant Medical(United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation